Am
Ambys Med
S San Francisco CAFounded 201850 employees
Private CapbiotechPrivateHepatology
Platform: Liver Regen
Market Cap
N/A
All Drugs
4
Clinical Trials
6
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| AMB-378 | AMB-378 | Phase 2 | 2 | BCMA | NASHPsA | ||
| AMB-4811 | AMB-4811 | Preclinical | 1 | ALK | SchizophreniaProstate Ca | ||
| AMB-7870 | AMB-7870 | Phase 3 | 2 | IL-13 | CMLADPKD | ||
| Doxaderotide | AMB-6806 | Phase 3 | 1 | SMN2 | T2DThymoma |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)